ClinicalTrials.Veeva

Menu

Improving Physical Activity Levels in the Arabic- Speaking Residents of East Jerusalem With Prediabetes

C

Clalit Health Services

Status

Unknown

Conditions

Diabetes Mellitus

Treatments

Behavioral: Activity tracker plus usual care
Behavioral: Personalized physical activity prescription
Behavioral: Motivational Interview support and Dietitian support

Study type

Interventional

Funder types

Other

Identifiers

NCT03821220
0201-17-COM2

Details and patient eligibility

About

This three-arm clinical trial aims to improve levels of physical activity among Arabic- speaking residents of East Jerusalem with prediabetes. Levels of daily physical activity (assessed through activity trackers), dietary habits and self-assessed health will be compared between patients that receive only the activity tracker and written information (group A), receive the activity tracker, written information and a personalized physical activity prescription (group B), and those that receive in addition also intensive follow-up with motivational interview by physician assistants and a dietitian (group C)

Full description

This is a three-arm clinical trial studying the effect of providing activity trackers with intensive motivational interview by trained physician assistants, and dietitian counselling, on the levels of daily physical activity among Arabic- speaking residents of East Jerusalem with prediabetes from Clalit Health Services. In addition, this study will also assess healthy dietary changes, and self assessed health and quality of life.

The study will compare three groups (total 375, each group 125):

Group A - will receive activity trackers and written educational handouts in addition to their usual care.

Group B - will receive all of group A intervention components and also a personalized physical activity prescription.

Group C - will receive all of group B components and also intensive motivational interview support by trained physician assistants (3 sessions), and dietitian support (two sessions).

Each participant will be followed-up for six months, with data collection occurring at baseline, three months and six months. Data collection will include average weekly steps, blood pressure, anthropometric measurements, routine blood tests (including fasting glucose, HbA1C, and lipid profile), physical activity survey, Mediterranean dietary habits survey, Food Frequency Questionnaire, and quality of life survey.

Enrollment

375 estimated patients

Sex

All

Ages

40 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Pre-diabetes patients - Impaired fasting glucose at least twice between 100-125 mg/dL in the two years prior to the study; or HbA1C 5.7%-6.4% twice in the two years prior to the study; or one test of fasting glucose of 100-125 mg/dL, and one test of HbA1C between 5.7%-6.4% in the two years prior to the study.

Exclusion criteria

  1. Diabetes including a doctor's diagnosis based on a medical file or a recurrence of fasting blood glucose values above 126 mg/dL in the year preceding the study or a glucose value greater than 200 mg/dL in the year prior to the study or HbA1C above 6.5%

  2. Treatment with diabetes drugs other than metformin, as prescribed in the medical file with regular or chronic medications

  3. Artificial lower limbs or inability to walk normally (eg: stroke with plegia)

  4. Chronic obstructive pulmonary disease

  5. Known heart disease (with impaired exercise tolerance)

  6. Pregnancy

  7. Medical conditions:

    • a cardiac event/ Transient ischemic attack in the last year
    • Cerebrovascular attack with residual impairment
    • Surgery that required hospitalization in the last year
    • Injury to lower limbs that prevents regular walking
    • Malignancy excluding skin cancer small cell carcinoma or basal cell carcinoma

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

375 participants in 3 patient groups

Group A
Active Comparator group
Description:
Patients will receive an activity tracker and written information for pre-diabetic, on top of their usual care.
Treatment:
Behavioral: Activity tracker plus usual care
Group B
Active Comparator group
Description:
Patients will receive an activity tracker, written information for pre-diabetic, and personalized physical activity prescription, on top of their usual care.
Treatment:
Behavioral: Personalized physical activity prescription
Behavioral: Activity tracker plus usual care
Group C
Active Comparator group
Description:
Patients will receive an activity tracker, written information for pre-diabetic, personalized physical activity prescription, three sessions of motivational interview support from trained physician assistants, and two session of dietitian support, on top of their usual care.
Treatment:
Behavioral: Personalized physical activity prescription
Behavioral: Motivational Interview support and Dietitian support
Behavioral: Activity tracker plus usual care

Trial contacts and locations

0

Loading...

Central trial contact

Amnon Lahad, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems